Detalhe da pesquisa
1.
Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial.
Cancer
; 127(5): 700-708, 2021 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33290610
2.
Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial.
Breast Cancer Res Treat
; 185(3): 697-707, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33159633
3.
Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy.
Breast Cancer Res Treat
; 181(2): 347-359, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32274665
4.
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 17(3): 367-377, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26874901
5.
CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
Breast Cancer Res Treat
; 151(2): 373-84, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25935582
6.
Bias in survival estimates created by a requirement for consent to enter a clinical breast cancer registry.
Cancer Epidemiol
; 58: 178-183, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30639876
7.
Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial.
J Clin Oncol
; 37(2): 105-114, 2019 01 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30475668
8.
Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The SOLD Randomized Clinical Trial.
JAMA Oncol
; 4(9): 1199-1206, 2018 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29852043
9.
A durable complete remission between two isolated presentations of metastatic breast cancer, the second with intracardiac disease.
Clin Breast Cancer
; 7(2): 162-3, 2006 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-16800977
10.
Medical resource utilization for administration of trastuzumab in a New Zealand oncology outpatient setting: a time and motion study.
Clinicoecon Outcomes Res
; 7: 423-30, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26251623
11.
Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 following chemotherapy for advanced breast cancer.
ANZ J Surg
; 73(11): 905-8, 2003 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-14616567
12.
Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer.
J Clin Oncol
; 29(34): 4498-504, 2011 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22025143
13.
Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.
J Natl Cancer Inst
; 102(16): 1253-62, 2010 Aug 18.
Artigo
Inglês
| MEDLINE | ID: mdl-20631341